2016-03-21 19:05:33 UTC

Gut Microbiota Imbalance Harms Liver

March 22, 2016

Hepatologists should review this fact sheet for an overview of the role of the gut microbiome in liver diseases.

The potential consequences of gut microbial dysbiosis are not restricted to bowel conditions. At the 2016 Gut Microbiota for Health World Summit earlier this month, Bernd G. Schnabl, MD, from the University of California, San Diego, presented on the role of the gut microbiome in liver diseases.

You can read an overview of Dr. Schnabl’s presentation in this fact sheet from the meeting. The fact sheet explains why diseases such as NAFLD, NASH, alcoholic liver disease and cirrhosis are associated with a disturbed microbial balance in the intestines, and explains the mechanisms behind the onset of these diseases.

More Microbiome Updates
Last week we shared information from the summit on the gut microbiome as a new kind of biomarker for GI diseases. Check out other fact sheets from the summit, as well as videos and infographics, by visiting the conference website.

Learn more about the gut microbiome by visiting the AGA Center for Gut Microbiome Research and Education.

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Oct. 11, 2017

Statin use is probably associated with lower risk of hepatic decompensation and mortality, and might reduce portal hypertension, in patients with CLDs.

Cirrhosis Presenting as Cutaneous Calciphylaxis

Oct. 11, 2017

A 73-year-old woman with a history of hypertension presented with a 3-month history of a painful, non-healing right calf ulcer and 2–3 weeks of painful, dusky purple patches on the right thigh.